Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bodhi Tree Biotechnology (BDTB) Income from Continuing Operations (2024 - 2025)

Historic Income from Continuing Operations for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q4 2025 value amounting to -$52948.0.

  • Bodhi Tree Biotechnology's Income from Continuing Operations rose 1826.11% to -$52948.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$137837.0, marking a year-over-year change of. This contributed to the annual value of -$149666.0 for FY2025, which is N/A changed from last year.
  • Latest data reveals that Bodhi Tree Biotechnology reported Income from Continuing Operations of -$52948.0 as of Q4 2025, which was up 1826.11% from -$10687.0 recorded in Q3 2025.
  • In the past 5 years, Bodhi Tree Biotechnology's Income from Continuing Operations ranged from a high of -$10687.0 in Q3 2025 and a low of -$64777.0 during Q4 2024